Innolake Biopharm Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
9
Innolake Biopharm General Information
Description
Developer of therapeutic drugs designed to overcome tumors and immune system diseases. The company offers research and development of therapeutic drugs and operates extensive product development pipelines, thereby enabling patients to receive better treatment and improve their health conditions.
Contact Information
Website
www.innolakebio.comCorporate Office
- 3-6F, Building 24, Yinhai Sci-Tech Innovation Center
- 501 Fucheng Road, Xiasha Street Qiantang District
- Hangzhou, Zhejiang 310018
- China
Corporate Office
- 3-6F, Building 24, Yinhai Sci-Tech Innovation Center
- 501 Fucheng Road, Xiasha Street Qiantang District
- Hangzhou, Zhejiang 310018
- China
Innolake Biopharm Timeline
Innolake Biopharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 24-Oct-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 05-Feb-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 04-Jun-2023 | $14.3M | $60.1M | Completed | Generating Revenue | |
| 1. Early Stage VC | 27-Apr-2021 | $45.9M | $45.9M | Completed | Generating Revenue |
Innolake Biopharm Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Haiwang Capital | Venture Capital | Minority | ||
| Shanghai Science & Technology Investment | Venture Capital | Minority | ||
| Heda Ventures | Venture Capital | Minority | ||
| WuXi Biologics | Corporation | Minority | ||
| Y.R.Delta Fund | Growth/Expansion | Minority |
Innolake Biopharm FAQs
-
When was Innolake Biopharm founded?
Innolake Biopharm was founded in 2020.
-
Where is Innolake Biopharm headquartered?
Innolake Biopharm is headquartered in Hangzhou, China.
-
What industry is Innolake Biopharm in?
Innolake Biopharm’s primary industry is Drug Discovery.
-
Is Innolake Biopharm a private or public company?
Innolake Biopharm is a Private company.
-
What is Innolake Biopharm’s current revenue?
The current revenue for Innolake Biopharm is .
-
How much funding has Innolake Biopharm raised over time?
Innolake Biopharm has raised $60.1M.
-
Who are Innolake Biopharm’s investors?
Haiwang Capital, Shanghai Science & Technology Investment, Heda Ventures, WuXi Biologics, and Y.R.Delta Fund are 5 of 9 investors who have invested in Innolake Biopharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process